VLS Retatrutide 20mg Pen — Triple-Action Incretin Research Peptide

Innovative VLS Retatrutide 20mg Pen formulation activating GLP-1, GIP and Glucagon pathways for cutting-edge fat-loss research.

Concentration & Quality

• 20 mg Retatrutide per prefilled pen
• Triple-receptor agonist (GLP-1 + GIP + Glucagon)
• Vitality Life Science (VLS) pharmaceutical standard

Key Features

• Triple-incretin activation for maximum fat oxidation
• Promotes appetite control and metabolic efficiency
• High-purity formulation for consistent research data

How to Use

Prefilled pen. Refrigerate at 2–8 °C. For research use only.

How It Works

Retatrutide combines three hormonal pathways (GLP-1, GIP, and Glucagon) to enhance satiety, increase energy expenditure and improve insulin response in metabolic research models.

Storage & Handling

Store refrigerated (2–8 °C). Avoid freezing. Protect from light and moisture.